Cantor Fitzgerald Reiterates Intellia Therapeutics (NTLA) Overweight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 29, 2023, Cantor Fitzgerald reiterated coverage of Intellia Therapeutics (NASDAQ:NTLA) with a Overweight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1438233969-08b4f322bd6f4c04b75978968d305bd5.jpg "How Is Your 401(k) Taxed in Retirement?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1614464221-ecb8ed53589e48fdb5e7f490b4e90a5c.jpg "<div>Cargill Stock Doesn’t Exist. Here's Why.</div>")
:max_bytes(150000):strip_icc():format(jpeg)/medicare101-bf80ac5ea86e47648d91b622fd7e497e.jpg "Learn the A, B, C, and Ds of Medicare: What Parts Do You Really Need?")